Rusan Pharma Ltd

Rusan Pharma is a global pharmaceutical company specializing in addiction and pain management treatments. We manufacture and market a wide range of APIs and finished formulations, focusing on controlled substances (narcotic and psychotropic). Our facilities are GMP-approved by USFDA, Health Canada, EU, TGA, ANVISA, PIC/S, WHO, Russia, and SAHPRA. We hold CEP approvals for APIs like Buprenorphine, Fentanyl, Naltrexone, and Methadone, and also manufacture Naloxone, Nalbuphine, Apomorphine, and more, including transdermal patches and long-acting formulations.